Syndax Pharmaceuticals (SNDX) Earnings
|
Expand Research on SNDX
| Next EPS Date | 8/4/26 *Est. | EPS Growth Rate | +100.0% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | +2.7% | Revenue Growth Rate | -100.0% *Last Qtr. |
| Average % Move 1-Wk after EPS | +5.1% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
5/11/26  |
Q126 | N/A | -$0.55 | N/A | N/A | $72.99M | N/A | N/A | N/A | ||
| 2/26/26 | Q425 | -$0.78 | -$0.59 | -$0.19 | $68.7M | $63.13M | N/A |  | | Details | |
| 11/3/25 | Q325 | -$0.70 | -$0.73 | +$0.03 | $45.9M | $47.75M | N/A | | | Details | |
| 8/4/25 | Q225 | -$0.83 | -$1.01 | +$0.18 | $37.96M | $27.13M | N/A | | | Details | |
| 5/5/25 | Q125 | -$0.98 | -$1.24 | +$0.26 | $20.04M | $14.84M | N/A | | | Details | |
| 3/3/25 |
Q424 | N/A | -$0.99 | N/A | N/A | $25.2M | N/A | N/A | N/A | ||
| 11/5/24 | Q324 | -$0.98 | -$1.07 | +$0.09 | $12.5M | $9.16M | N/A | | | Details | |
| 8/1/24 | Q224 | -$0.80 | -$0.91 | +$0.11 | $3.5M | N/A | N/A | | | Details |
